<DOC>
	<DOC>NCT03093545</DOC>
	<brief_summary>A single center, prospective cohort, open-label study of rabies post exposure program with equine rabies immunoglobulin (ERIG) and purified chick-embryo cell (PCEC) rabies vaccine in WHO category III exposed patients at Siriraj Hospital, Thailand aims to compare serum RVNA responses between obese (BMI &gt; 30 kg/m2) and normal weight/underweight (BMI &lt; 25 kg/m2) and to evaluate adverse events occurring after immunization on days 7, 14 and 28.</brief_summary>
	<brief_title>Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients</brief_title>
	<detailed_description>A single center, prospective cohort, open-label study of rabies post exposure program with equine rabies immunoglobulin (ERIG) and purified chick-embryo cell (PCEC) rabies vaccine in WHO category III exposed patients at Siriraj Hospital, Thailand aims to compare serum RVNA responses between obese (BMI &gt; 30 kg/m2) and normal weight/underweight (BMI &lt; 25 kg/m2) and to evaluate adverse events occurring after immunization on days 7, 14 and 28.</detailed_description>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>1. Male or female ages of &gt;= 18 years and older; 2. Experienced WHO category III rabies exposure excluding presenting wound at eye(s) or eye lid(s); 3. Either a) obese with BMI &gt;= 30 or b) normal weight and/or underweight with BMI &lt; 25; 4. Agree to independently consent to participate in all study procedures. 1. Positive skin test to ERIG or known hypersensitivity to ERIG or its excipients; 2. Coenrolment with other studies or participated in other investigational drug studies or use of other investigational drugs within 4 weeks or five times the halflife of the investigational drug; 3. Female patients who are currently pregnant or breast feeding. 4. Presenting with wound at eye(s) or eye lid(s); 5. Receiving rabies vaccination more than 7 days for this exposure; 6. History of complete preexposure or postexposure regimen with at least 3 doses; 7. Known of allergic to egg or poultry meat; 8. History of previous exposure to equine sera 9. Significant illness that might harm or increase the risk to the patients; 10. History of drug abuse or alcoholism.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>rabies</keyword>
	<keyword>obese</keyword>
	<keyword>immunoglobulin</keyword>
	<keyword>rabies vaccine</keyword>
	<keyword>post-exposure</keyword>
	<keyword>immunogenicity</keyword>
</DOC>